377 related articles for article (PubMed ID: 38073096)
1. Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms.
Liu S; He Y; Zhang Y; Zhang Z; Huang K; Deng L; Liao B; Zhong Y; Feng J
Gut Microbes; 2023 Dec; 15(2):2290331. PubMed ID: 38073096
[TBL] [Abstract][Full Text] [Related]
2. Update on gut microbiota in cardiovascular diseases.
Qian B; Zhang K; Li Y; Sun K
Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
4. Interaction between gut microbiome and cardiovascular disease.
Peng J; Xiao X; Hu M; Zhang X
Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and microbiota-derived metabolites in cardiovascular diseases.
Chen X; Zhang H; Ren S; Ding Y; Remex NS; Bhuiyan MS; Qu J; Tang X
Chin Med J (Engl); 2023 Oct; 136(19):2269-2284. PubMed ID: 37442759
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota in Hypertension and Atherosclerosis: A Review.
Verhaar BJH; Prodan A; Nieuwdorp M; Muller M
Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003455
[TBL] [Abstract][Full Text] [Related]
7. Understanding connections and roles of gut microbiome in cardiovascular diseases.
Rajendiran E; Ramadass B; Ramprasath V
Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota.
Zhao L; Lou H; Peng Y; Chen S; Fan L; Li X
Diabetes Res Clin Pract; 2020 Nov; 169():108418. PubMed ID: 32891692
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota derived metabolites in cardiovascular health and disease.
Wang Z; Zhao Y
Protein Cell; 2018 May; 9(5):416-431. PubMed ID: 29725935
[TBL] [Abstract][Full Text] [Related]
10. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
[TBL] [Abstract][Full Text] [Related]
11. The Role of Gut Microbiota and Trimethylamine N-oxide in Cardiovascular Diseases.
Huang Y; Zhang H; Fan X; Wang J; Yin Y; Zhang Y; Shi K; Yu F
J Cardiovasc Transl Res; 2023 Jun; 16(3):581-589. PubMed ID: 36251229
[TBL] [Abstract][Full Text] [Related]
12. Implication of Gut Microbiota in Cardiovascular Diseases.
Zhou W; Cheng Y; Zhu P; Nasser MI; Zhang X; Zhao M
Oxid Med Cell Longev; 2020; 2020():5394096. PubMed ID: 33062141
[TBL] [Abstract][Full Text] [Related]
13. Interactions between polysaccharides and gut microbiota: A metabolomic and microbial review.
Zhang D; Liu J; Cheng H; Wang H; Tan Y; Feng W; Peng C
Food Res Int; 2022 Oct; 160():111653. PubMed ID: 36076442
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota is a potential goalkeeper of dyslipidemia.
Lei L; Zhao N; Zhang L; Chen J; Liu X; Piao S
Front Endocrinol (Lausanne); 2022; 13():950826. PubMed ID: 36176475
[TBL] [Abstract][Full Text] [Related]
15. Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases.
Yntema T; Koonen DPY; Kuipers F
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111068
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review).
Zhu Y; Shui X; Liang Z; Huang Z; Qi Y; He Y; Chen C; Luo H; Lei W
Int J Mol Med; 2020 Sep; 46(3):936-948. PubMed ID: 32705240
[TBL] [Abstract][Full Text] [Related]
17. Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease.
Al Samarraie A; Pichette M; Rousseau G
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982492
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota-Derived Metabolites and Cardiovascular Disease Risk: A Systematic Review of Prospective Cohort Studies.
Sanchez-Gimenez R; Ahmed-Khodja W; Molina Y; Peiró OM; Bonet G; Carrasquer A; Fragkiadakis GA; Bulló M; Bardaji A; Papandreou C
Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807835
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?
Cao H; Zhu Y; Hu G; Zhang Q; Zheng L
Pharmacol Res; 2023 Jan; 187():106586. PubMed ID: 36460280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]